Skip to main content

CONSOLIDATED EDISON INC

For the period ended Dec 31, 2024. Filed Feb 20, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 20, 2025

ED$118.39-0.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Financial Statement Schedules

Schedule I

Condensed Statement of Income and Comprehensive Income

For the Years Ended December 31,
(Millions of Dollars, except per share amounts)202420232022
Equity in earnings of subsidiaries$1,904$1,759$1,860
Other operating and maintenance expenses(1)—(1)
Taxes other than income taxes(12)(2)(7)
Other income (deductions)(14)7(31)
Interest expense(18)(14)(32)
Income tax benefit (expense)23(96)(129)
Gain (Loss) on the sale of the Clean Energy Businesses(62)865—
Net Income$1,820$2,519$1,660
Comprehensive Income$1,827$2,520$1,677
Net Income Per Share – Basic$5.26$7.25$4.68
Net Income Per Share – Diluted$5.24$7.21$4.66
Dividends Declared Per Share$3.32$3.24$3.16
Average Number Of Shares Outstanding—Basic (In Millions)346.0347.7354.5
Average Number Of Shares Outstanding—Diluted (In Millions)347.3349.3355.8

(a)These financial statements, in which Con Edison’s subsidiaries have been included using the equity method, should be read together with its consolidated financial statements and the notes thereto appearing above.

Condensed Statement of Cash Flows

For the Years Ended December 31,
(Millions of Dollars)202420232022
Net Cash Flows From Operating Activities$1,204$772$1,015
Investing Activities
Contributions to subsidiaries(175)(1,854)(150)
Proceeds from sale of the Clean Energy Businesses, net of cash and cash equivalents sold—3,927—
Net Cash Flows From (Used in) Investing Activities(175)2,073(150)
Financing Activities
Net issuance (payment) of short-term debt957232
Issuance of term loan—200400
Retirement of term loan—(600)—
Retirement of long-term debt—(650)(293)
Repurchase of common shares—(1,000)—
Issuance of common shares for stock plans605657
Common stock dividends(1,100)(1,096)(1,089)
Net Cash Flows Used in Financing Activities(1,031)(3,033)(693)
Net Change for the Period(2)(188)172
Balance at Beginning of Period319119
Balance at End of Period$1$3$191

(a)These financial statements, in which Con Edison’s subsidiaries have been included using the equity method, should be read together with its consolidated financial statements and the notes thereto appearing above.

Condensed Balance Sheet

December 31,
(Millions of Dollars)20242023
Assets
Current Assets
Cash and temporary cash investments$1$3
Other receivables, net allowance for uncollectible accounts64103
Tax receivable1451
Accounts receivable from affiliated companies300343
Accrued unbilled revenue34
Prepayments13109
Other current assets13
Total Current Assets527566
Investments in subsidiaries and others21,70620,778
Goodwill406406
Pension and retiree benefits - asset65
Other deferred charges and noncurrent assets356249
Total Assets$23,001$22,004
Liabilities and Shareholders’ Equity
Current Liabilities
Notes payable$348$339
Accounts payable1730
Accounts payable to affiliated companies1412
Accrued taxes215
Accrued taxes to affiliated companies646437
Other current liabilities98
Total Current Liabilities1,036841
Other noncurrent liabilities45
Total Liabilities1,040846
Shareholders’ Equity
Common stock, including additional paid-in capital10,0249,898
Retained earnings11,93711,260
Total Shareholders’ Equity21,96121,158
Total Liabilities and Shareholders’ Equity$23,001$22,004

(a)These financial statements, in which Con Edison’s subsidiaries have been included using the equity method, should be read together with its consolidated financial statements and the notes thereto appearing above.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.